Entinostat enhances antitumor immune responses and cooperates with PD-1 blockade in bladder cancer mouse models.

被引：0
|
作者：
Truong, Andrew S. [1 ]
Zhou, Mi [1 ]
Utsumi, Takanobu [1 ]
Krishnan, Bhavani [1 ]
Stewart, Kyle G. [1 ]
Saito, Ryoichi [1 ]
Manocha, Ujjawal [1 ]
Bailey, Sean T. [1 ]
Kim, William Y. [1 ]
机构：
[1] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
来源：
CLINICAL CANCER RESEARCH | 2020年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A13
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [31] Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer
    Zhang, Yu
    Wang, Fei
    Sun, Hao-ran
    Huang, Ya-kai
    Gao, Jian-peng
    Huang, Hua
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (08) : 2209 - 2222
  • [32] The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer
    Zhao, Zihan
    Liu, Siyang
    Sun, Rui
    Zhu, Wenjie
    Zhang, Yulin
    Liu, Tianyao
    Li, Tianhang
    Jiang, Ning
    Guo, Hongqian
    Yang, Rong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [33] Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer
    Yu Zhang
    Fei Wang
    Hao-ran Sun
    Ya-kai Huang
    Jian-peng Gao
    Hua Huang
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2209 - 2222
  • [34] Blockade of LAG-3 amplifies immune activation signatures and augments curative antitumor responses to anti-PD-1 therapy in immune competent mouse models of cancer
    Haines, Brian B.
    Javaid, Sarah
    Cui, Long
    Hirsch, Heather
    Cemerski, Saso
    McClanahan, Terri
    Sathe, Manjiri
    Zhang, Shuli
    Rosenzweig, Michael
    Long, Brian
    Malefyt, Rene de Waal
    CANCER RESEARCH, 2017, 77
  • [35] Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a Mouse Model of Subcutaneous Tumor
    Shindo, Yoshitaro
    Yoshimura, Kiyoshi
    Kuramasu, Atsuo
    Watanabe, Yusaku
    Ito, Hideaki
    Kondo, Tomoko
    Oga, Atsunori
    Ito, Hiroshi
    Yoshino, Shigefumi
    Hazama, Shoichi
    Tamada, Koji
    Yagita, Hideo
    Oka, Masaaki
    ANTICANCER RESEARCH, 2015, 35 (01) : 129 - 136
  • [36] The Novel Combination of Nitroxoline and PD-1 Blockade, Exerts a Potent Antitumor Effect in a Mouse Model of Prostate Cancer
    Xu, Naijin
    Huang, Linglong
    Li, Xiezhao
    Watanabela, Masami
    Li, Chaoming
    Xu, Abai
    Liu, Chunxiao
    Li, Qiang
    Araki, Motoo
    Wada, Koichiro
    Nasu, Yasutomo
    Huang, Peng
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (05): : 919 - 928
  • [37] PD-1 blockade therapy enhances the antitumor effects of lymphodepletion and adoptive T cell transfer
    Watanabe, Satoshi
    Takahashi, Miho
    Suzuki, Ryo
    Arita, Masashi
    Sato, Ko
    Fujisaki, Toshiya
    Ohtsubo, Aya
    Shoji, Satoshi
    Shono, Kunihiro
    Masuda, Takaaki
    Sekiya, Tomoki
    Nozaki, Koichiro
    Tanaka, Tomohiro
    Kondo, Rie
    Saida, Yu
    Hokari, Satoshi
    Koya, Toshiyuki
    Kikuchi, Toshiaki
    CANCER RESEARCH, 2023, 83 (07)
  • [38] Combination Therapy with Bispecific Antibodies and PD-1 Blockade Enhances the Antitumor Potency of T Cells
    Chang, Chien-Hsing
    Wang, Yang
    Li, Rongxiu
    Rossi, Diane L.
    Liu, Donglin
    Rossi, Edmund A.
    Cardillo, Thomas M.
    Goldenberg, David M.
    CANCER RESEARCH, 2017, 77 (19) : 5384 - 5394
  • [39] Immune metabolism in PD-1 blockade-based cancer immunotherapy
    Kumar, Alok
    Chamoto, Kenji
    INTERNATIONAL IMMUNOLOGY, 2021, 33 (01) : 17 - 26
  • [40] Enhancement of immune checkpoint PD-1 blockade efficacy in ovarian cancer
    Drakes, Maureen
    Mehrotra, Swati
    Potkul, Ronald
    Liu, Yueying
    Stack, M. Sharon
    Stiff, Patrick
    CANCER RESEARCH, 2018, 78 (13)
12345